Authors


Andre J. Witkin, MD

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


Jay S. Duker, MD

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


Nadia K. Waheed, MD, MPH

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability






Netan Choudhry, MD

Latest:

The subthreshold laser’s role in retinal vascular disease

Combination therapy benefits from laser in the mix for DME, other conditions


Munir Escaf, MD

Latest:

Laser therapy may offer fast-acting option for CSR resolution

Patients tolerate therapy well; high safety profile allows re-treatment as necessary


Alex Delaney-Gesing

Latest:

Update on FDA approval of XIPERE for macular edema associated with uveitis from Bausch + Lomb

Bausch + Lomb's Yolande Barnard shares an update on the FDA approval of XIPERE for the treatment of macular edema associated with uveitis.


OT Staff Reports

Latest:

Comparing suitable naïve versus pre-treated DME patients

Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.


Rishi P. Singh, MD

Latest:

DR/DME: Ongoing Clinical Trials and New Diagnostic Tools

Carolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss new and upcoming clinical trials, investigational therapies, and diagnostic tools for the treatment of diabetic retinopathy and diabetic macular edema (DR/DME).


Nimesh A. Patel, MD

Latest:

FISH in focus for fast eye infection diagnosis

Despite cost, advantages include sensitivity, improved outcomes



Pauline T. Merrill, MD

Latest:

ST laser therapy may reduce DME intravitreal injections

Used as an adjunct, ST laser therapy may reduce the treatment burden for patients while maintaining visual acuity.




© 2024 MJH Life Sciences

All rights reserved.